ImmuCell Corp (ICCC)
5.090
+0.06
(+1.19%)
USD |
NASDAQ |
May 06, 16:00
5.11
+0.02
(+0.39%)
Pre-Market: 20:00
ImmuCell Total Liabilities (Quarterly): 18.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.82M |
| September 30, 2023 | 18.53M |
| June 30, 2023 | 17.15M |
| March 31, 2023 | 14.96M |
| December 31, 2022 | 14.48M |
| September 30, 2022 | 14.42M |
| June 30, 2022 | 13.21M |
| March 31, 2022 | 13.33M |
| December 31, 2021 | 11.89M |
| September 30, 2021 | 11.77M |
| June 30, 2021 | 11.46M |
| March 31, 2021 | 11.75M |
| December 31, 2020 | 12.08M |
| September 30, 2020 | 11.97M |
| June 30, 2020 | 12.38M |
| March 31, 2020 | 11.06M |
| December 31, 2019 | 9.701M |
| September 30, 2019 | 9.659M |
| June 30, 2019 | 9.764M |
| March 31, 2019 | 10.23M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 10.56M |
| June 30, 2018 | 9.927M |
| March 31, 2018 | 10.14M |
| December 31, 2017 | 10.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 9.336M |
| June 30, 2017 | 7.866M |
| March 31, 2017 | 4.965M |
| December 31, 2016 | 4.975M |
| September 30, 2016 | 4.171M |
| June 30, 2016 | 4.267M |
| March 31, 2016 | 4.059M |
| December 31, 2015 | 3.926M |
| September 30, 2015 | 3.925M |
| June 30, 2015 | 1.339M |
| March 31, 2015 | 1.486M |
| December 31, 2014 | 1.794M |
| September 30, 2014 | 1.617M |
| June 30, 2014 | 1.664M |
| March 31, 2014 | 1.724M |
| December 31, 2013 | 1.565M |
| September 30, 2013 | 1.554M |
| June 30, 2013 | 1.929M |
| March 31, 2013 | 1.698M |
| December 31, 2012 | 1.836M |
| September 30, 2012 | 1.772M |
| June 30, 2012 | 1.779M |
| March 31, 2012 | 1.924M |
| December 31, 2011 | 1.971M |
| September 30, 2011 | 1.984M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.659M
Minimum
Sep 2019
18.82M
Maximum
Dec 2023
13.07M
Average
12.08M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.81M |
| Shareholders Equity (Quarterly) | 24.99M |
| Debt to Equity Ratio | 0.4789 |
| Current Ratio | 2.733 |
| Net Debt Paydown Yield | -0.76% |